We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
MAP3K8 (C-Terminus) antibody
MAP3K8, c-COT, Cancer Osaka Thyroid Oncogene, Cancer Osaka Thyroid Oncogene, COT, Cot proto-oncogene serine/threonine-protein kinase, EST, ESTF, FLJ10486, MEKK8, Protein kinase cot, Tpl-2, TPL2, Tumor progression locus 2
Out of stock
Ref
00018573
MAP3K8 (C-Terminus) antibody
ID Covalab | pab71681 |
---|---|
Product type | Primary antibodies |
Clonality | Polyclonal antibody |
Raised in | Rabbit |
Immunogen | Synthetic 18 amino acid peptide from near C-terminus of human MAP3K8. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Gibbon (100%), Marmoset (100%), Elephant (100%), Bovine (100%), Dog (100%), Bat (100%) |
Activity cross reaction | Reacts with human MAP3K8. BLAST analysis of the peptide immunogen showed no homology with other human proteins. |
Species | Hu |
Labelling | None |
Form | Antigen affinity purified |
Preservative | NaN3 0.1% |
Storage instructions | Long term: -70°C; Short term: +4°C |
Target | MAP3K8 |
Accession Number | P41279 |
Applications | IHC - P |
Working dilutions | IHC-P (10 µg/ml) |
Write Your Own Review